Pharmacyclics Inc (PCYC :)
| Extended Hours | --- |
---
|
--- | --- |
|
--- |
---
|
--- | --- |
PCYC FEATURED NEWS & ANALYSIS
MORE FROM OUR PARTNERS
-
6 Superstars For Your Biotech Portfolio: John McCamant 10 May 2013 - Seeking Alpha
-
Cellceutix Corporation: The Next Generation Of Cancer Treatment Has Ar... 09 May 2013 - Seeking Alpha
-
Recent Noteworthy Institutional 5% Ownership Filings In Healthcare Sec... 09 May 2013 - Seeking Alpha
-
Top Small-Cap Biotech Stocks Being Accumulated By Large Fund Managers 07 May 2013 - Seeking Alpha
-
Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential 03 May 2013 - Seeking Alpha
-
Pharmacyclics Management Discusses Q1 2013 Results - Earnings Call Tra... 01 May 2013 - Seeking Alpha
-
Biotech Stocks Get A Turbo Boost From Vertex 20 Apr 2013 - Seeking Alpha
LATEST TRANSCRIPTS
-
Pharmacyclics Management Discusses Q1 2013 Results - Earnings Call Tra... 01 May 2013 - Seeking Alpha
PRESS RELEASES
-
Janssen Oncology Data to be Presented at 2013 American Society of Clin... 15 May 2013 - PR Newswire
-
Ibrutinib Expanded Access Program Open to Eligible U.S. Patients with ... 06 May 2013 - PR Newswire
-
Pharmacyclics Reports First Quarter 2013 Results 01 May 2013 - PR Newswire
-
Daratumumab Receives Breakthrough Therapy Designation in Double Refrac... 01 May 2013 - PR Newswire
-
Pharmacyclics Announces Date of Financial Results for Three Months End... 24 Apr 2013 - PR Newswire
-
Research and Markets: Refractory Chronic Lymphocytic Leukemia (CLL) - ... 22 Apr 2013 - Business Wire
-
Pharmacyclics Completes Enrollment of First Phase III Ibrutinib CLL St... 18 Apr 2013 - PR Newswire
